Breast cancer is the most common cancer in women and is often diagnosed when the condition worsens.
However, scientists now claim to have developed a blood test that can help detect breast cancer 5 years before any symptoms.
Cancer cells produce proteins called antigens (TAs) that force the body to produce antibodies against them.
Researchers from the University of Nottingham, UK, have discovered that these anti-genomes linked to Rasooli may be indicative of cancer, and a simple blood test will identify the physiological immune response to the substance that causes the thought of the messenger.
Researchers took blood samples from 90 breast cancer patients when they were diagnosed and compared them with samples from 90 patients who did not have breast cancer.
Researchers used the screening technology to quickly detect the presence of antibodies against anti-TAEs linked to breast cancer in blood samples.
“The results of the research prove that antibodies against breast cancer antigens are active, and we can accurately diagnose cancer by the presence of these antibodies in the blood,” he said.
According to the research, a panel of 5 TAs was correctly identified in cancer patients and correctly diagnosed in 84% of cancer-free samples.
Researchers say we need to build and improve this test, but the current results are encouraging and may help early diagnosis of breast cancer. “Once we improve its acuity, a blood sample will open the door to catch the disease sooner,” he said.
Now scientists are testing it on a sample of 800 patients, and they estimate that the test will be available in hospitals over the next 4 to 5 years.